Pharmafile Logo

pmlive

- PMLiVE

PMLiVE’s T40 – now open for submissions!

Healthcare agencies can submit their entries free of charge with a deadline of 30 October

- PMLiVE

PMLiVE’s Top Pharma list is live

The data was provided by GlobalData, a data analysis and consulting company

- PMLiVE

Full impact of COVID-19 pandemic on cancer treatment unknown, according to GlobalData

World Cancer Day (4 February 2021) is aiming to address systemic weaknesses exacerbated by pandemic

- PMLiVE

Immuno-oncology, personalised medicine continues to drive pharma sector

New GlobalData survey identifies key trends impacting the industry

- PMLiVE

Personalised medicine can improve treatment, but access still an issue

Barriers to access could harm uptake of potentially transformative therapies

- PMLiVE

Bedrock are in the Top 3

Bedrock named No. 3 Young Agency by PMLive

Bedrock Healthcare Communications

The good, the bad and the ugly

Tracking the pharmaceutical industry’s 2017 evolution and assessing how things may shape up in 2018 - it’s a trilogy of trends

- PMLiVE

Neurodegenerative research needs better cooperation, say GlobalData

And public funding must be provided to eradicate business risks

Sanofi reception

Type 1 diabetes market to double to $13.6bn

New treatments will see this growth by 2023, according to GlobalData

- PMLiVE

US pharma market to reach $550bn by 2020

Health reforms and the new FDA initiatives among the factors that will help it grow

- PMLiVE

Medical device M&A hit ‘all-time high’ in 2014

Deals last year were led by Medtronic’s acquisition of Covidien

- PMLiVE

Patent cliff losses set to cost pharma $65bn by 2019

Lilly, AZ and Otsuka to be hit hard, says GlobalData

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links